Grupo Oncologico Cooperativo del Sur

Grupo Oncológico Cooperativo del Sur (GOCS) is a prominent Argentine cooperative research organization dedicated to the advancement of clinical oncology through multicenter trials. Established to foster collaboration among oncologists in the region, the group conducts both independent academic research and industry-sponsored Phase 2 and Phase 3 clinical studies. GOCS provides a robust infrastructure for high-quality data collection and therapeutic evaluation, playing a vital role in the Latin American clinical research ecosystem. Their work spans a wide range of solid tumors, with significant contributions to the treatment of breast, colorectal, and lung cancers. By partnering with international research networks and global pharmaceutical companies, GOCS aims to optimize therapeutic strategies and improve patient outcomes across South America.